Analysis of patenting trends of antifungal drugs in the product patent regime in India

Rupsa Gupta and Padmavati Manchikanti

World Patent Information, 2010, vol. 32, issue 2, 135-140

Abstract: The present study attempts to analyze the patenting activity of antifungal drugs in the pre and post TRIPS period in India. There is a general increase in patent filing in antifungals both by Indian as well as by multinational companies, with greater filing by the latter in the post-TRIPS era. The major filings in the transition and post-TRIPS period have been due to increased product than process patent filings, wherein 75% of the total patent applications in this sector is directed towards product patents and remaining 25% is directed towards process patents. It is observed that Indian academic institutions have been more active than foreign institutions with respect to patent filings in this field.

Keywords: Antifungal; drugs; Indian; pharmaceutical; industry; Patents; Anti-infective; sector; TRIPS (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0172-2190(09)00041-6
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:worpat:v:32:y:2010:i:2:p:135-140

Ordering information: This journal article can be ordered from
http://www.elsevier.com/wps/find/supportfaq.cws_home/regional
http://www.elsevier. ... _01_ooc_1&version=01

Access Statistics for this article

World Patent Information is currently edited by Michael Blackman

More articles in World Patent Information from Elsevier
Bibliographic data for series maintained by Catherine Liu ().